DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

COMPLETE CARE PREMIUM WITH SMART REPORT

BLOOD COUNTS,EDTA WHOLE BLOOD
HEMOGLOBIN (HB) 10.6 Low 13.0 - 17.0 g/dL
METHOD : SPECTROPHOTOMETRY

RED BLOOD CELL (RBC) COUNT 5.58 High 4.5 - 5.5 mil/µL
METHOD : ELECTRONIC IMPEDANCE

WHITE BLOOD CELL (WBC) COUNT 5.80 4.0 - 10.0 thou/µL

METHOD : ELECTRICAL IMPEDENCE / MICROSCOPIC EXAMINATION

PLATELET COUNT 265 150 - 410 thou/µL

METHOD : ELECTRONIC IMPEDANCE

RBC AND PLATELET INDICES

HEMATOCRIT (PCV) 35.2 Low 40 - 50 %
METHOD : CALCULATED PARAMETER

MEAN CORPUSCULAR VOLUME (MCV) 63.0 Low 83 - 101 fL

METHOD : CALCULATED PARAMETER

MEAN CORPUSCULAR HEMOGLOBIN (MCH) 19.1 Low 27.0 - 32.0 pg

METHOD : CALCULATED PARAMETER

MEAN CORPUSCULAR HEMOGLOBIN 30.2 Low 31.5 - 34.5 g/dL

CONCENTRATION (MCHC)
METHOD : CALCULATED PARAMETER

RED CELL DISTRIBUTION WIDTH (RDW) 17.1 High 11.6 - 14.0 %

METHOD : CALCULATED PARAMETER

MENTZER INDEX 11.3

MEAN PLATELET VOLUME (MPV) 8.7 6.8 - 10.9 fL
METHOD : CALCULATED PARAMETER

WBC DIFFERENTIAL COUNT

NEUTROPHILS 56 40 - 80 %
METHOD : ABSORBANCE SPECTROPHOTOMETRY/ MICROSCOPY

LYMPHOCYTES 38 20 - 40 %
MONOCYTES 03 2 - 10 %
METHOD : ABSORBANCE SPECTROPHOTOMETRY/ MICROSCOPY

EOSINOPHILS 03 1-6 %
METHOD : ABSORBANCE SPECTROPHOTOMETRY/ MICROSCOPY

BASOPHILS 00 0-2 %
ABSOLUTE NEUTROPHIL COUNT 3.25 2.0 - 7.0 thou/µL

Page 1 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

METHOD : CALCULATED PARAMETER

ABSOLUTE LYMPHOCYTE COUNT 2.20 1.0 - 3.0 thou/µL

METHOD : CALCULATED PARAMETER

ABSOLUTE MONOCYTE COUNT 0.17 Low 0.2 - 1.0 thou/µL

METHOD : CALCULATED PARAMETER

ABSOLUTE EOSINOPHIL COUNT 0.17 0.02 - 0.50 thou/µL

METHOD : CALCULATED PARAMETER

ABSOLUTE BASOPHIL COUNT 0 Low 0.02 - 0.10 thou/µL

METHOD : CALCULATED PARAMETER

NEUTROPHIL LYMPHOCYTE RATIO (NLR) 1.5

ERYTHROCYTE SEDIMENTATION RATE (ESR),WHOLE
BLOOD
E.S.R 03 0 - 14 mm at 1 hr
METHOD : RATE OF FALL OF RED CELLS(SEDIMENTATION) MODIFIED WESTERGREN,S METHOD.

PERIPHERAL SMEAR EXAM, EDTA WHOLE BLOOD

RBC MICROCYTIC HYPOCHROMIC , PREDOMINANTLY.
NO NUCLEATED RBC/INCLUSION SEEN.
NO PARASITE SEEN.

METHOD : MICROSCOPIC EXAMINATION

WBC NORMAL IN COUNT, MORPHOLOGY AND DISTRIBUTION.

NO IMMATURE CELLS SEEN.

METHOD : MICROSCOPIC EXAMINATION

PLATELETS ADEQUATE ON SMEAR.

METHOD : MICROSCOPIC EXAMINATION

IMPRESSION MICROCYTIC HYPOCHROMIC ANEMIA.

GLUCOSE FASTING,FLUORIDE PLASMA
FBS (FASTING BLOOD SUGAR) 94 74 - 99 mg/dL

Page 2 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

GLYCOSYLATED HEMOGLOBIN(HBA1C), EDTA WHOLE

BLOOD
HBA1C 4.8 Non-diabetic: < 5.7 %
Pre-diabetics: 5.7 - 6.4
Diabetics: > or = 6.5
ADA Target: 7.0
Action suggested: > 8.0
METHOD : HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

ESTIMATED AVERAGE GLUCOSE(EAG) 91.1 < 116.0 mg/dL

Page 3 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

HIGH SENSITIVITY C-REACTIVE PROTEIN, SERUM

HIGH SENSITIVITY CRP 1.17 0.00 - 3.00 mg/L
LIVER FUNCTION PROFILE, SERUM
BILIRUBIN, TOTAL 1.50 High 0.2 - 1.0 mg/dL
METHOD : SPECTROPHOTOMETRY

BILIRUBIN, DIRECT 0.35 High 0.0 - 0.2 mg/dL

METHOD : DIAZOTIZED SULFANULIC ACD / SPECTOPHOTOMETER

BILIRUBIN, INDIRECT 1.15 High 0.1 - 1.0 mg/dL

METHOD : SPECTROPHOTOMETRY/ CALCULATION

TOTAL PROTEIN 7.1 6.4 - 8.2 g/dL

ALBUMIN 3.9 3.4 - 5.0 g/dL
GLOBULIN 3.2 2.0 - 4.1 g/dL
ALBUMIN/GLOBULIN RATIO 1.2 1.0 - 2.1 RATIO
ASPARTATE AMINOTRANSFERASE (AST/SGOT) 30 15 - 37 U/L
ALANINE AMINOTRANSFERASE (ALT/SGPT) 58 High < 45.0 U/L
METHOD : SPECTROPHOTOMETRY, UV WITH PYRIDOXAL -5-PHOSPHATE

ALKALINE PHOSPHATASE 62 30 - 120 U/L

Page 4 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

GAMMA GLUTAMYL TRANSFERASE (GGT) 33 15 - 85 U/L

LACTATE DEHYDROGENASE 187 100 - 190 U/L
TOTAL IRON BINDING CAPACITY, SERUM
IRON 124 65 - 175 µg/dL
METHOD : SPECTROPHOTOMETRY

TOTAL IRON BINDING CAPACITY 282 250 - 450 µg/dL

METHOD : SPECTROPHOTOMETRY

% SATURATION 44 13 - 45 %
METHOD : SPECTROPHOTOMETRY

25 - HYDROXYVITAMIN D(VITAMIN D TOTAL), SERUM

25 - HYDROXYVITAMIN D 12.27 Low Deficiency: ng/mL
< 20.0
Insufficiency:
20.0 - < 30.0
Sufficiency:
30.0 -100.0
Toxicity > 100.0
METHOD : ELECTROCHEMILUMINESCENCE, COMPETITIVE IMMUNOASSAY

CALCIUM, SERUM
CALCIUM 9.1 8.5 - 10.1 mg/dL
METHOD : OCPC/CRESOLPHTHALIN / SPECTOPHOTOMETER

VITAMIN B12(CYANOCOBALAMINE), SERUM

VITAMIN B12 140.7 Low 197 - 771 pg/mL
METHOD : ELECTROCHEMILUMINESCENCE, COMPETITIVE IMMUNOASSAY

LIPID PROFILE, SERUM

CHOLESTEROL, TOTAL 156 < 200 Desirable mg/dL
200 - 239 Borderline High
>/= 240 High
METHOD : CHOLESTEROL OXIDASE / SPECTOPHOTOMETER

TRIGLYCERIDES 80 < 150 Normal mg/dL

150 - 199 Borderline High
200 - 499 High
>/=500 Very High
METHOD : CHROMOGEN FERENE / SPECTOPHOTOMETER

HDL CHOLESTEROL 48 < 40 Low mg/dL

>/=60 High

Page 5 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

LDL CHOLESTEROL, DIRECT 75 < 100 Optimal mg/dL

100 - 129 Near or above optimal
130 - 159 Borderline High
160 - 189 High
>/= 190 Very High
METHOD : HOMOGENOUS METHOD / SPECTOPHOTOMETER

NON HDL CHOLESTEROL 108 Desirable: Less than 130 mg/dL

Above Desirable: 130 - 159
Borderline High: 160 - 189
High: 190 - 219
Very high: > or = 220
CHOL/HDL RATIO 3.3 3.3 - 4.4 Low Risk
4.5 - 7.0 Average Risk
7.1 - 11.0 Moderate Risk
> 11.0 High Risk
LDL/HDL RATIO 1.6 0.5 - 3.0 Desirable/Low Risk
3.1 - 6.0 Borderline/Moderate Risk
>6.0 High Risk
VERY LOW DENSITY LIPOPROTEIN 16.0 </= 30.0 mg/dL

Page 6 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

Page 7 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

BLOOD UREA NITROGEN (BUN), SERUM

BLOOD UREA NITROGEN 8 6 - 20 mg/dL
METHOD : GLDH / UREASE / SPECTOPHOTOMETER

Page 8 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

CREATININE, SERUM
CREATININE 1.00 0.90 - 1.30 mg/dL
METHOD : PICRATE/ JAFFE / SPECTOPHOTOMETER

BUN/CREAT RATIO
BUN/CREAT RATIO 8.00 5.00 - 15.00
URIC ACID, SERUM
URIC ACID 6.8 3.5 - 7.2 mg/dL
METHOD : URICASE/ CATALASE UV/ SPECTOPHOTOMETER

TOTAL PROTEIN, SERUM

TOTAL PROTEIN 7.1 6.4 - 8.2 g/dL
METHOD : BIURET / HENRY2/ MICROSCOPIC / SPECTOPHOTOMETER

ALBUMIN, SERUM
ALBUMIN 3.9 3.4 - 5.0 g/dL
METHOD : BCP DYE BINDING / SPECTOPHOTOMETER

GLOBULIN
GLOBULIN 3.2 2.0 - 4.1 g/dL
ELECTROLYTES (NA/K/CL), SERUM

Page 9 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

SODIUM, SERUM 139 136 - 145 mmol/L

METHOD : ION EXCHANGE CHROMATOGRAPHY

POTASSIUM, SERUM 4.20 3.50 - 5.10 mmol/L

METHOD : ION EXCHANGE CHROMATOGRAPHY

CHLORIDE, SERUM 102 98 - 107 mmol/L

METHOD : ION EXCHANGE CHROMATOGRAPHY

PHYSICAL EXAMINATION, URINE

COLOR PALE YELLOW
APPEARANCE CLEAR
CHEMICAL EXAMINATION, URINE
PH 5.5 4.7 - 7.5
SPECIFIC GRAVITY 1.020 1.003 - 1.035
PROTEIN NOT DETECTED NOT DETECTED
GLUCOSE NOT DETECTED NOT DETECTED
KETONES NOT DETECTED NOT DETECTED
BLOOD NOT DETECTED NOT DETECTED
BILIRUBIN NOT DETECTED NOT DETECTED
UROBILINOGEN NORMAL NORMAL
NITRITE NOT DETECTED NOT DETECTED
LEUKOCYTE ESTERASE NOT DETECTED NOT DETECTED
MICROSCOPIC EXAMINATION, URINE
RED BLOOD CELLS NOT DETECTED NOT DETECTED /HPF
PUS CELL (WBC’S) 1-2 0-5 /HPF
EPITHELIAL CELLS 1-2 0-5 /HPF
CASTS NOT DETECTED
CRYSTALS NOT DETECTED
BACTERIA NOT DETECTED NOT DETECTED
YEAST NOT DETECTED NOT DETECTED
FREE TRIIODOTHYRONINE (FT3), SERUM
FREE TRIIODOTHYRONINE (FT3) 3.87 2.0 - 4.4 pg/mL
METHOD : ELECTROCHEMILUMINESCENCE, COMPETITIVE IMMUNOASSAY

FREE THYROXINE (FT4), SERUM

FREE THYROXINE (FT4) 1.40 0.93 - 1.70 ng/dL

Page 10 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

METHOD : ELECTROCHEMILUMINESCENCE, COMPETITIVE IMMUNOASSAY

TSH 3RD GENERATION ULTRASENSITIVE, SERUM

TSH (ULTRASENSITIVE) 2.770 0.270 - 4.200 µIU/mL
METHOD : ELECTROCHEMILUMINESCENCE,SANDWICH IMMUNOASSAY

Interpretation(s)
BLOOD COUNTS,EDTA WHOLE BLOOD-
The cell morphology is well preserved for 24hrs. However after 24-48 hrs a progressive increase in MCV and HCT is observed leading to a decrease in MCHC. A direct smear
is recommended for an accurate differential count and for examination of RBC morphology.
RBC AND PLATELET INDICES-
Mentzer index (MCV/RBC) is an automated cell-counter based calculated screen tool to differentiate cases of Iron deficiency anaemia(>13) from Beta thalassaemia trait
(<13) in patients with microcytic anaemia. This needs to be interpreted in line with clinical correlation and suspicion. Estimation of HbA2 remains the gold standard for
diagnosing a case of beta thalassaemia trait.
WBC DIFFERENTIAL COUNT-
The optimal threshold of 3.3 for NLR showed a prognostic possibility of clinical symptoms to change from mild to severe in COVID positive patients. When age = 49.5 years
old and NLR = 3.3, 46.1% COVID-19 patients with mild disease might become severe. By contrast, when age < 49.5 years old and NLR < 3.3, COVID-19 patients tend to
show mild disease.
(Reference to - The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients A.-P. Yang, et al. International Immunopharmacology 84 (2020) 106504
This ratio element is a calculated parameter and out of NABL scope.
ERYTHROCYTE SEDIMENTATION RATE (ESR),WHOLE BLOOD-TEST DESCRIPTION :-
Erythrocyte sedimentation rate (ESR) is a test that indirectly measures the degree of inflammation present in the body. The test actually measures the rate of fall
(sedimentation) of erythrocytes in a sample of blood that has been placed into a tall, thin, vertical tube. Results are reported as the millimetres of clear fluid (plasma) that
are present at the top portion of the tube after one hour. Nowadays fully automated instruments are available to measure ESR.

ESR is not diagnostic it is a non-specific test that may be elevated in a number of different conditions. It provides general information about the presence of an
inflammatory condition.CRP is superior to ESR because it is more sensitive and reflects a more rapid change.
TEST INTERPRETATION
Increase in: Infections, Vasculities, Inflammatory arthritis, Renal disease, Anemia, Malignancies and plasma cell dyscrasias, Acute allergy Tissue injury, Pregnancy,
Estrogen medication, Aging.
Finding a very accelerated ESR(>100 mm/hour) in patients with ill-defined symptoms directs the physician to search for a systemic disease (Paraproteinemias,
Disseminated malignancies, connective tissue disease, severe infections such as bacterial endocarditis).
In pregnancy BRI in first trimester is 0-48 mm/hr(62 if anemic) and in second trimester (0-70 mm /hr(95 if anemic). ESR returns to normal 4th week post partum.
Decreased in: Polycythermia vera, Sickle cell anemia

LIMITATIONS
False elevated ESR : Increased fibrinogen, Drugs(Vitamin A, Dextran etc), Hypercholesterolemia
False Decreased : Poikilocytosis,(SickleCells,spherocytes),Microcytosis, Low fibrinogen, Very high WBC counts, Drugs(Quinine,
salicylates)

REFERENCE :
1. Nathan and Oski’s Haematology of Infancy and Childhood, 5th edition 2. Paediatric reference intervals. AACC Press, 7th edition. Edited by S. Soldin 3. The reference for
the adult reference range is “Practical Haematology by Dacie and Lewis,10th edition.
GLUCOSE FASTING,FLUORIDE PLASMA-TEST DESCRIPTION
Normally, the glucose concentration in extracellular fluid is closely regulated so that a source of energy is readily available to tissues and sothat no glucose is excreted in the
urine.
Increased in
Diabetes mellitus, Cushing’ s syndrome (10 – 15%), chronic pancreatitis (30%). Drugs:corticosteroids,phenytoin, estrogen, thiazides.
Decreased in
Pancreatic islet cell disease with increased insulin,insulinoma,adrenocortical insufficiency, hypopituitarism,diffuse liver disease, malignancy (adrenocortical,
stomach,fibrosarcoma), infant of a diabetic mother, enzyme deficiency diseases(e.g., galactosemia),Drugs- insulin,
ethanol, propranolol sulfonylureas,tolbutamide, and other oral hypoglycemic agents.
NOTE:
Hypoglycemia is defined as a glucoseof < 50 mg/dL in men and< 40 mg/dL in women.
While random serum glucose levels correlate with home glucose monitoring results (weekly mean capillary glucose values), there is wide fluctuation within individuals.Thus,
glycosylated hemoglobin(HbA1c) levels are favored to monitor glycemic control.
High fasting glucose level in comparison to post prandial glucose level may be seen due to effect of Oral Hypoglycaemics & Insulin treatment, Renal Glyosuria, Glycaemic

Page 11 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

index & response to food consumed, Alimentary Hypoglycemia, Increased insulin response & sensitivity etc.
GLYCOSYLATED HEMOGLOBIN(HBA1C), EDTA WHOLE BLOOD-Used For:

1.Evaluating the long-term control of blood glucose concentrations in diabetic patients.

2.Diagnosing diabetes.
3.Identifying patients at increased risk for diabetes (prediabetes).
The ADA recommends measurement of HbA1c (typically 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for
well-controlled type 2 diabetic patients) to determine whether a patients metabolic control has remained continuously within the target range.
1.eAG (Estimated average glucose) converts percentage HbA1c to md/dl, to compare blood glucose levels.
2. eAG gives an evaluation of blood glucose levels for the last couple of months.
3. eAG is calculated as eAG (mg/dl) = 28.7 * HbA1c - 46.7

HbA1c Estimation can get affected due to :

I.Shortened Erythrocyte survival : Any condition that shortens erythrocyte survival or decreases mean erythrocyte age (e.g. recovery from acute blood loss,hemolytic
anemia) will falsely lower HbA1c test results.Fructosamine is recommended in these patients which indicates diabetes control over 15 days.
II.Vitamin C & E are reported to falsely lower test results.(possibly by inhibiting glycation of hemoglobin.
III.Iron deficiency anemia is reported to increase test results. Hypertriglyceridemia,uremia, hyperbilirubinemia, chronic alcoholism,chronic ingestion of salicylates & opiates
addiction are reported to interfere with some assay methods,falsely increasing results.
IV.Interference of hemoglobinopathies in HbA1c estimation is seen in
a.Homozygous hemoglobinopathy. Fructosamine is recommended for testing of HbA1c.
b.Heterozygous state detected (D10 is corrected for HbS & HbC trait.)
c.HbF > 25% on alternate paltform (Boronate affinity chromatography) is recommended for testing of HbA1c.Abnormal Hemoglobin electrophoresis (HPLC method) is
recommended for detecting a hemoglobinopathy
HIGH SENSITIVITY C-REACTIVE PROTEIN, SERUM-
High sensitivity CRP measurements may be used as an independent risk marker for the identification of individuals at risk for future cardiovascular disease. Measurement of
hs- CRP, when used in conjunction with traditional clinical laboratory evaluation of acute coronary syndromes, may be useful as an independent marker of prognosis for
recurrent events, in patients with stable coronary disease or acute coronary syndromes.
When using this assay for risk assessment, patients with persistently unexplained, marked elevation of hs- CRP (> 10mg/l) after repeated testing should be evaluated for
non cardiovascular etiologies. In Rheumatic and other inflammatory diseases, value of CRP less than 10 mg/l is considered satisfactory. More than 10 mg/l suggests disease
activity. Patients with evidence of active infection, systemic inflammatory processes or trauma should not be tested for cardiovascular disease risk assessment until these
conditions have abated
Hs- CRP levels should not be substituted for assessment of traditional cardiovascular risk factors.
Turbidity and particles in the sample may interfere with the determination. Patient samples which contain heterophilic antibodies could react in immunoassays to give a
falsely elevated or depressed result.
Results of this test should always be interpreted in conjunction with the patient’s medical history, clinical presentation and other findings.

References:

1. Teitz textbook of clinical chemistry and Molecular diagnostics, edited by Carl A Burtis, Edward R. Ashrwood, David E Bruns, 4th edition, Elseiver publication, 2006,962-966
2. Parson TA, Mensah GA, et al. Marker of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation 2003,107,499-511
3. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice: Jacyln Anderson, Liron Caplin et al, Wiley
online, 2012.
LIVER FUNCTION PROFILE, SERUM-
LIVER FUNCTION PROFILE
Bilirubin is a yellowish pigment found in bile and is a breakdown product of normal heme catabolism. Bilirubin is excreted in bile and urine, and elevated levels may give
yellow discoloration in jaundice.Elevated levels results from increased bilirubin production (eg, hemolysis and ineffective erythropoiesis), decreased bilirubin excretion (eg,
obstruction and hepatitis), and abnormal bilirubin metabolism (eg, hereditary and neonatal jaundice). Conjugated (direct) bilirubin is elevated more than unconjugated
(indirect) bilirubin in Viral hepatitis, Drug reactions, Alcoholic liver disease Conjugated (direct) bilirubin is also elevated more than unconjugated (indirect) bilirubin when
there is some kind of blockage of the bile ducts like in Gallstones getting into the bile ducts, tumors &Scarring of the bile ducts. Increased unconjugated (indirect) bilirubin
may be a result of Hemolytic or pernicious anemia, Transfusion reaction & a common metabolic condition termed Gilbert syndrome, due to low levels of the enzyme that
attaches sugar molecules to bilirubin.
AST is an enzyme found in various parts of the body. AST is found in the liver, heart, skeletal muscle, kidneys, brain, and red blood cells, and it is commonly measured
clinically as a marker for liver health. AST levels increase during chronic viral hepatitis, blockage of the bile duct, cirrhosis of the liver,liver cancer,kidney failure,hemolytic
anemia,pancreatitis,hemochromatosis. AST levels may also increase after a heart attack or strenuous activity.ALT test measures the amount of this enzyme in the blood.ALT
is found mainly in the liver, but also in smaller amounts in the kidneys,heart,muscles, and pancreas.It is commonly measured as a part of a diagnostic evaluation of
hepatocellular injury, to determine liver health.AST levels increase during acute hepatitis,sometimes due to a viral infection,ischemia to the liver,chronic
hepatitis,obstruction of bile ducts,cirrhosis.
ALP is a protein found in almost all body tissues.Tissues with higher amounts of ALP include the liver,bile ducts and bone.Elevated ALP levels are seen in Biliary obstruction,
Osteoblastic bone tumors, osteomalacia, hepatitis, Hyperparathyroidism, Leukemia, Lymphoma, Paget's disease,Rickets,Sarcoidosis etc. Lower-than-normal ALP levels seen
in Hypophosphatasia,Malnutrition,Protein deficiency,Wilson's disease.GGT is an enzyme found in cell membranes of many tissues mainly in the liver,kidney and pancreas.It
is also found in other tissues including intestine,spleen,heart, brain and seminal vesicles.The highest concentration is in the kidney,but the liver is considered the source of
normal enzyme activity.Serum GGT has been widely used as an index of liver dysfunction.Elevated serum GGT activity can be found in diseases of the liver,biliary system
and pancreas.Conditions that increase serum GGT are obstructive liver disease,high alcohol consumption and use of enzyme-inducing drugs etc.Serum total protein,also

Page 12 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

known as total protein,is a biochemical test for measuring the total amount of protein in serum.Protein in the plasma is made up of albumin and globulin.Higher-than-normal
levels may be due to:Chronic inflammation or infection,including HIV and hepatitis B or C,Multiple myeloma,Waldenstrom's disease.Lower-than-normal levels may be due to:
Agammaglobulinemia,Bleeding (hemorrhage),Burns,Glomerulonephritis,Liver disease, Malabsorption,Malnutrition,Nephrotic syndrome,Protein-losing enteropathy etc.Human
serum albumin is the most abundant protein in human blood plasma.It is produced in the liver.Albumin constitutes about half of the blood serum protein.Low blood albumin
levels (hypoalbuminemia) can be caused by:Liver disease like cirrhosis of the liver, nephrotic syndrome,protein-losing enteropathy,Burns,hemodilution,increased vascular
permeability or decreased lymphatic clearance,malnutrition and wasting etc
TOTAL IRON BINDING CAPACITY, SERUM-
Total iron binding capacity (TIBC) measures the blood’s capacity to bind iron with transferrin and thus is an indirect way of assessing transferrin level.
Taken together with serum iron and percent transferrin saturation this test is performed when they is a concern about anemia, iron deficiency or iron deficiency anemia.
However, because the liver produces transferrin, alterations in liver function (such as cirrhosis, hepatitis, or liver failure) must be considered when performing this test.
Increased in:
- iron deficiency
- acute and chronic blood loss
- acute liver damage
- progesterone birth control pills
Decreased in:
- hemochromatosis
- cirrhosis of the liver
- thalassemia
- anemias of infection and chronic diseases
- nephrosis
- hyperthyroidism
The percent Transferrin saturation = Serum Iron/TIBC x 100
Unsaturated Binding Capacity (UIBC)=TIBC - Serum Iron.
Limitations: Estrogens and oral contraceptives increase TIBC and Asparaginase, chloramphenicol, corticotropin, cortisone and testosterone decrease the TIBC level.

Reference:
1.Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, edited by Carl A Burtis, Edward R.Ashwood, David E Bruns, 4th Edition, Elsevier publication, 2006, 563,
1314-1315.
2. Wallach’s Interpretation of Diagnostic tests, 9th Edition, Ed Mary A Williamson and L Michael Snyder. Pub Lippincott Williams and Wilkins, 2011, 234-235.
25 - HYDROXYVITAMIN D(VITAMIN D TOTAL), SERUM-Test description
Vitamin D has anti-inflammatory and immune-modulating properties and it works towards the bones, teeth, intestines, immune system, pancreas, muscles and brain. It
helps to maintain normal calcium and phosphate levels.Vitamin D is a fat-soluble vitamin. Also called as “Sunshine Vitamin”.Two main forms as Cholecalciferol (vitamin D3)
which is synthesized in skin from 7-dehydrocholesterol in response to sunlight (Type B UV) exposure & Ergocalciferol (vitamin D2) present mainly in dietary sources.
Vit D25(OH)D deficiency is seen due to poor or inadequate sunlight exposure, Nutritional or dietary deficiency or fat malabsorption, Severe Hepatocellular disease,
Secondary hyperparathyroidism, Hypocalcemia tetany which can cause involuntary contraction of muscles, leading to cramps and spasms, Rickets in children, Osteomalacia
in adults- due to vitamin D deficiency mainly, Older adults- osteoporosis. (Increased risk of bone fractures)due to long-term effect of calcium and/or vitamin D deficiency,
Other conditions that are precipitated by Vit D deficiency included increased cardiovascular risk, low immunity & chronic renal failure.
Elevated levels may be seen in patients taking supplements( hence recommended to repeat after 3 months for estimation of accurate levels), Vitamin D intoxication,
sarcoidosis and malignancies containing non regulated 1-alpha hydroxylase in the lesion.
Recommendations
1.To prevent biotin interference the patient should be atleast 8 hours fasting before submitting the sample 2.25(OH)D is the analyte of choice for determination of the
Vitamin D status as it is the major storage & active form of Vitamin D and has longer half-life. 3. Kidney Disease Outcomes Quality Initiatives (KDOQI) and Kidney Disease
Improving Global Outcomes (KDIGO) recommend activated vitamin D testing for CKD patients.
Note-Our Vitamin D assays is standardized to be in alignment with the ID-LC/MS/MS 25(OH)vitamin D Reference Method Procedure (RMP), the reference procedure for the
Vitamin D Standardization Program (VDSP). The VDSP, a collaboration of the National Institutes of Health Office of Dietary Supplements, National Institute of Technology
and Standards, Centers for Disease Control and Ghent University, is an initiative to standardize 25(OH)vitamin D measurement across methods.
Reference:
1.Wallach's Interpretation of diagnostic test, 10th edition.
CALCIUM, SERUM-
Commom causes of decreased value of calcium (hypocalcemia) are chronic renal failure, hypomagnesemia and hypoalbuminemia.

Hypercalcemia (increased value of calcium) can be caused by increased intestinal absorbtion (vitamin d intoxication), increased skeletal reasorption
(immobilization), or a combination of mechanisms (primary hyperparathyroidism). Primary hyperparathyroidism and malignancy accounts for 90-95% of all cases of
hypercalcemia.

Values of total calcium is affected by serum proteins, particularly albumin thus, latter’s value should be taken into account when interpreting serum calcium
levels. The following regression equation may be helpful.
Corrected total calcium (mg/dl)= total calcium (mg/dl) + 0.8 (4- albumin [g/dl])*
because regression equations vary among group of patients in different physiological and pathological conditions, mathematical corrections are only
approximations. The possible mathematical corrections should be replaced by direct determination of free calcium by ISE (available with srl) a common and
important source of preanalytical error in the measurement of calcium is prolonged torniquet application during sampling. Thus, this along with fist clenching
should be avoided before phlebotomy.

Page 13 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

VITAMIN B12(CYANOCOBALAMINE), SERUM-Test description

1.Measures the amount of Vitamin B12/ Cyanocobalamin or Methyl cobalamin in blood.2. Done in Anemic conditions like Megaloblastic anemia, pernicious anemia, dietary
folate deficiencies,3.Workup of neuropathies especially due to diabetes.4.Nerve health and it is monitored in treatment of nerve damage.5.Important vitamin for women of
childbearing age and for older people.
1.Part of water-soluble B complex of vitamins. 2. It is essential in DNA synthesis, hematopoiesis & CNS integrity.3.Source for B12 is dietary foods like milk, yoghurt, eggs,
meat, fortified cereals, bread. 4.Absorption depends on the HCl secreted by the stomach and occurs in intestines. 5. It is part of enterohepatic circulation, hence excreted in
feces(approx. 0.1% per day)
Test interpretation
Higher than normal levels are in patients on Vitamin supplements or patients with COPD, CRF, Diabetes, Liver cell damage, Obesity, Polycythemia.
Decreased levels seen in
Inflammatory bowel disease, Pernicious anemia - genetic deficiency of intrinsic factor - necessary for Vit B12 absorption, Strict vegetarianslead to sub-clinical B12
deficiency- high among elderly patients, Malabsorption due to gastrectomy, smoking, pregnancy, multiple myeloma & hemodialysis, Alcohol & drugs like amino salicylic acid,
anticonvulsants, cholestyramine, cimetidine, Hyperthyroidism (High levels of thyroid), Seen in mothers of children with (NTD) Neural tube defects- hence fortification and
supplements are advised in expecting mothers
Recommendations-1.To prevent biotin interference the patient should be atleast 8 hours fasting before submitting the sample. 2. Vit B12 and Folic acid evaluated together
in macrocytic anemias to avoid methyl folate trap. Carmel’s composite criteria for inadequate Vit B12 status: Serum vitamin B12 < 148 pmol/L, or 148–258 pmol/L and
MMA > 0.30µmol/L, or tHcy > 13 nmol/L (females) and >15 nmol/L (males).
Associated Test-Holo-TC: Marker of vitamin B12 status -specificity and sensitivity better than serum vitamin B12, hence recommended in boderline and deficient cases for
confirmation.
References-O''Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010 Mar 2(3):299-316.
LIPID PROFILE, SERUM-Serum cholesterol is a blood test that can provide valuable information for the risk of coronary artery disease This test can help determine your risk
of the build up of plaques in your arteries that can lead to narrowed or blocked arteries throughout your body (atherosclerosis). High cholesterol levels usually don''''''''''''''''t
cause any signs or symptoms, so a cholesterol test is an important tool. High cholesterol levels often are a significant risk factor for heart disease and important for
diagnosis of hyperlipoproteinemia, atherosclerosis, hepatic and thyroid diseases.

Serum Triglyceride are a type of fat in the blood. When you eat, your body converts any calories it doesn''''''''''''''''t need into triglycerides, which are stored in fat cells. High
triglyceride levels are associated with several factors, including being overweight, eating too many sweets or drinking too much alcohol, smoking, being sedentary, or having
diabetes with elevated blood sugar levels. Analysis has proven useful in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other
diseases involving lipid metabolism, and various endocrine disorders. In conjunction with high density lipoprotein and total serum cholesterol, a triglyceride determination
provides valuable information for the assessment of coronary heart disease risk.It is done in fasting state.

High-density lipoprotein (HDL) cholesterol. This is sometimes called the ""good"" cholesterol because it helps carry away LDL cholesterol, thus keeping arteries open and
blood flowing more freely.HDL cholesterol is inversely related to the risk for cardiovascular disease. It increases following regular exercise, moderate alcohol consumption
and with oral estrogen therapy. Decreased levels are associated with obesity, stress, cigarette smoking and diabetes mellitus.

SERUM LDL The small dense LDL test can be used to determine cardiovascular risk in individuals with metabolic syndrome or established/progressing coronary artery
disease, individuals with triglyceride levels between 70 and 140 mg/dL, as well as individuals with a diet high in trans-fat or carbohydrates. Elevated sdLDL levels are
associated with metabolic syndrome and an ‘atherogenic lipoprotein profile’, and are a strong, independent predictor of cardiovascular disease.
Elevated levels of LDL arise from multiple sources. A major factor is sedentary lifestyle with a diet high in saturated fat. Insulin-resistance and pre-diabetes have also been
implicated, as has genetic predisposition. Measurement of sdLDL allows the clinician to get a more comprehensive picture of lipid risk factors and tailor treatment
accordingly. Reducing LDL levels will reduce the risk of CVD and MI.

Non HDL Cholesterol - Adult treatment panel ATP III suggested the addition of Non-HDL Cholesterol as an indicator of all atherogenic lipoproteins (mainly LDL and VLDL).
NICE guidelines recommend Non-HDL Cholesterol measurement before initiating lipid lowering therapy. It has also been shown to be a better marker of risk in both primary
and secondary prevention studies.

Recommendations:
Results of Lipids should always be interpreted in conjunction with the patient’s medical history, clinical presentation and other findings.

NON FASTING LIPID PROFILE includes Total Cholesterol, HDL Cholesterol and calculated non-HDL Cholesterol. It does not include triglycerides and may be best used in
patients for whom fasting is difficult.
BLOOD UREA NITROGEN (BUN), SERUM-Causes of Increased levels include Pre renal (High protein diet, Increased protein catabolism, GI haemorrhage, Cortisol,
Dehydration, CHF Renal), Renal Failure, Post Renal (Malignancy, Nephrolithiasis, Prostatism)
Causes of decreased level include Liver disease, SIADH.
CREATININE, SERUM-Higher than normal level may be due to:
• Blockage in the urinary tract
• Kidney problems, such as kidney damage or failure, infection, or reduced blood flow
• Loss of body fluid (dehydration)
• Muscle problems, such as breakdown of muscle fibers
• Problems during pregnancy, such as seizures (eclampsia)), or high blood pressure caused by pregnancy (preeclampsia)

Lower than normal level may be due to:

• Myasthenia Gravis

Page 14 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

• Muscular dystrophy
URIC ACID, SERUM-
Causes of Increased levels:-Dietary(High Protein Intake,Prolonged Fasting,Rapid weight loss),Gout,Lesch nyhan syndrome,Type 2 DM,Metabolic syndrome
Causes of decreased levels-Low Zinc intake,OCP,Multiple Sclerosis
TOTAL PROTEIN, SERUM-
Serum total protein,also known as total protein, is a biochemical test for measuring the total amount of protein in serum..Protein in the plasma is made up of albumin and
globulin

Higher-than-normal levels may be due to: Chronic inflammation or infection, including HIV and hepatitis B or C, Multiple myeloma, Waldenstrom's disease
Lower-than-normal levels may be due to: Agammaglobulinemia, Bleeding (hemorrhage),Burns,Glomerulonephritis, Liver disease, Malabsorption, Malnutrition, Nephrotic
syndrome,Protein-losing enteropathy etc.
ALBUMIN, SERUM-
Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin constitutes about half of the blood serum protein. Low
blood albumin levels (hypoalbuminemia) can be caused by: Liver disease like cirrhosis of the liver, nephrotic syndrome, protein-losing enteropathy, Burns, hemodilution,
increased vascular permeability or decreased lymphatic clearance,malnutrition and wasting etc.
FREE TRIIODOTHYRONINE (FT3), SERUM-
FREE T3 :T3 is bound to thyroxine binding globulin(TBG),prealbumin, and albumin. Only 0.2-0.4% of the total T3 is present in solution as unbound or free T3.This free
fraction represents the physiologically active thyroid hormone.

Free T3 and Free T4 values therefore, provide the best indication of thyroid dysfunction, instead of Total T3 or Total T4, since these are not affected by changes in the
serum binding proteins. Free T3 is typically elevated to a greater degree than free thyroxine (T4) in Graves’ disease.
Occasionally, free T3 alone is elevated (T3 thyrotoxicosis) in about 5% of the hyperthyroid population. In contrast, levels of free T4 are elevated to a greater degree than
free T3 in toxic multinodular goiter and excessive T4 therapy. Serum free T3 is useful in distinguishing these forms of hyperthyroidism.
Free T3 may also be important in monitoring patients on anti-thyroid therapy where treatment is focused on reducing the T3 production and the T4 conversion to T3. Serum
free T3 may also be useful in assessing the severity of the thyrotoxic state.
FREE THYROXINE (FT4), SERUM-
Thyroxine(T4)circulates in the blood as an equilibrium mixture of free and serum protein bound hormone. Less than 0.03% is present in the circulation as unbound, free T4.
This small percentage of the total T4 represents the physiologically available hormone which is biologically active.
Free T3 and Free T4 values therefore, provide the best indication of thyroid dysfunction, instead of Total T3 or Total T4, since these are not affected by changes in the
serum binding proteins. Free T3 is typically elevated to a greater degree than free thyroxine (T4) in Graves’ disease.
Occasionally, free T3 alone is elevated (T3 thyrotoxicosis) in about 5% of the hyperthyroid population. In contrast, levels of free T4 are elevated to a greater degree than
free T3 in toxic multinodular goiter and excessive T4 therapy. Serum free T3 is useful in distinguishing these forms of hyperthyroidism.
Free T3 may also be important in monitoring patients on anti-thyroid therapy where treatment is focused on reducing the T3 production and the T4 conversion to T3. Serum
free T3 may also be useful in assessing the severity of the thyrotoxic state.
TSH 3RD GENERATION ULTRASENSITIVE, SERUM-TSH stands for thyroid stimulating hormone. This hormone stimulates the Thyroid gland to make thyroid hormones that
regulate the way our body uses energy. These also play an important role in regulating weight, temperature, muscle strength, and even your mood. TSH is made in a gland
in the brain called the pituitary. When thyroid levels in our body are low, the pituitary gland makes more TSH. When thyroid levels are high, the pituitary gland makes less
TSH. TSH levels that are too high or too low can indicate that thyroid is not working correctly.

There is a circadian rhythm of TSH secretion, with peak values at the onset of sleep and nadir concentrations during the afternoon hours. Peak and nadir concentrations
differ by approximately +/- 50%. The effect on circulating T4 and T3 concentrations is not significant because of the large size of the extrathyroidal T4 pool.
In healthy subjects there is no significant impact of body weight, physical training, body habitus, posture, immobilization, mild to moderate exercise, or ambulatory status
on thyroid function, and no significant geographic environmental variation.
Nutrition also has a minimal impact except for variation in iodine intake. Subthreshold concentrations of iodine intake are associated with increased TSH secretion, goiter,
increased thyroid iodine uptake, decreased T4 production, an increased T3/T4 secretion ratio, and an increased ratio of circulating T3/T4 concentrations. Excessive iodine
intake can block thyroid hormone biosynthesis by inhibiting the enzymes involved in the biosynthetic process, resulting in reduced T4 secretion, increased TSH
concentrations, goiter, and hypothyroidism if the iodine excess is chronic.

High TSH levels can mean your thyroid is not making enough thyroid hormones, a condition called hypothyroidism. Low TSH levels can mean your thyroid is making too
much of the hormones, a condition called hyperthyroidism. A TSH test does not explain why TSH levels are too high or too low.
In cases of Subclinical hypothyroidism, a single test can be misleading, so a second test is usually done 2 or 3 months later. In both tests, the blood is taken at the same
time of day because TSH levels can fluctuate over the course of 24 hours. Subclinical hypothyroidism is diagnosed when both TSH readings are high but the thyroid
hormone thyroxine is still within the normal range.
Being severely overweight and certain medications can also increase TSH. TSH levels are likely to fluctuate more during pregnancy.
TSH values may be transiently altered because of Non thyroidal Illness like severe infections, liver disease, renal failure, heart failure, severe burns, trauma, surgery etc.
TSH levels that are slightly or only moderately elevated do not necessarily need to be treated. Some people who have high TSH levels never even develop symptoms.
It is also very common for TSH levels to return to normal in children and teenagers.
The following tables give the reference ranges in children and pregnant women.
REF: 1. TIETZ Fundamentals of Clinical chemistry 2Guidlines of the American Thyroid association during pregnancy and Postpartum,2011.
**End Of Report**
Please visit www.srlworld.com for related Test Information for this accession

Page 15 Of 16

Scan to View Details Scan to View Report

 DIAGNOSTIC REPORT

Patient Ref. No. 775000001875476

CLIENT CODE : C000071106

CLIENT'S NAME AND ADDRESS :

MYSRL # MOBILE CHANNEL JALANDHAR <b>SRL Ltd</b>
7,GUJRAL NAGAR, BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN 7,GUJRAL NAGAR,BHAGWAN MAHAVIR MARG, NEAR DOORDARSHAN
KENDRA, KENDRA
GOREGAON (WEST), JALANDHAR, 144001
JALANDHAR 144001 PUNJAB, INDIA
PUNJAB INDIA Tel : 9111591115, Fax : CIN - U74899PB1995PLC045956
Email : [email protected]

PATIENT NAME : ZAHEEN JAIN PATIENT ID : ZAHEM21038927

ACCESSION NO : 0010VK001835 AGE : 33 Years SEX : Male ABHA NO :

DRAWN : 15/11/2022 09:00:00 RECEIVED : 15/11/2022 11:39:32 REPORTED : 15/11/2022 13:38:13

REFERRING DOCTOR : DR. null CLIENT PATIENT ID : ZAHEM21038927

Test Report Status Final Results Biological Reference Interval Units

Dr. Raman Preet Kaur

LAB HEAD

CONDITIONS OF LABORATORY TESTING & REPORTING

1. It is presumed that the test sample belongs to the patient 5. The results of a laboratory test are dependent on the
named or identified in the test requisition form. quality of the sample as well as the assay technology.
2. All Tests are performed and reported as per the 6. Result delays could be because of uncontrolled
turnaround time stated in the SRL Directory of services circumstances. e.g. assay run failure.
(DOS). 7. Tests parameters marked by asterisks are excluded from
3. SRL confirms that all tests have been performed or the “scope" of NABL accredited tests. (If laboratory is
assayed with highest quality standards, clinical safety & accredited).
technical integrity. 8. Laboratory results should be correlated with clinical
4. A requested test might not be performed if: information to determine Final diagnosis.
a. Specimen received is insufficient or inappropriate 9. Test results are not valid for Medico- legal purposes.
specimen quality is unsatisfactory 10. In case of queries or unexpected test results please call
b. Incorrect specimen type at SRL customer care (91115 91115). Post proper
c. Request for testing is withdrawn by the ordering doctor investigation repeat analysis may be carried out.
or patient
d. There is a discrepancy between the label on the
specimen container and the name on the test requisition
form
SRL Limited
Fortis Hospital, Sector 62, Phase VIII,
Mohali 160062

Page 16 Of 16

Scan to View Details Scan to View Report